Precision BioSciences Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- Precision BioSciences's estimated revenue is currently $23.6M per year.
- Precision BioSciences received $40.0M in venture funding in March 2019.
- Precision BioSciences's estimated revenue per employee is $144540
- Precision BioSciences's total funding is $153.3M.
- Precision BioSciences has 163 Employees.
- Precision BioSciences grew their employee count by 43% last year.
- Precision BioSciences currently has 26 job openings.
|Neil Leatherbury||Director of Formulation|
|Jessica Danieli||Director, Office of the CEO|
|Sinu Bhandaru||Senior Director, Head of Operations and Information Technology|
|Dan MacLeod||Associate Director, Cell Therapy|
|Cindy Patterson||Director, Human Resources|
|Jeffrey Sunman||Director, Intellectual Property|
|Matthew Kane||Chief Executive Officer, Co-Founder|
|Dave Morris||VP, Therapeutic Discovery|
|Bruce Stevens||Senior Director, Quality and Compliance|
|Damien Hallet||Director - Head of CMC Technical Operations|
What Is Precision BioSciences?
Precision BioSciences is a privately held biotechnology company dedicated to improving lives through its next generation gene editing technology, ARCUS. Precision's cell therapy, gene therapy, and agriculture programs are based on the proprietary ARC endonuclease, which features coordinated target site binding and DNA cutting to ensure precise edits. Our team includes pioneers in genome engineering, biotech business leaders, and a staff of committed Precisioneers. We work together in our beautifully designed, award-winning space in vibrant downtown Durham, NC; a place with great restaurants and museums as well as fantastic housing and schools. Precision provides all employees a sense of purpose, thoughtfully designed laboratory and office spaces, and opportunities to train and grow not to mention plentifully stocked kitchens and benefits like wellness massage. At Precision BioSciences, we are excited to work together toward improving lives by realizing the potential of gene editing.keywords:Biotechnology,Cleantech,Food & Beverages,Healthcare,Medical Diagnostics,Pharmaceuticals,Wind Power
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Precision BioSciences News
DURHAM, N.C., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (DTIL) (“Precision”), a genome editing company dedicated ...
DURHAM, N.C., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (DTIL) (“Precision”), a genome editing company dedicated ...
DURHAM, N.C., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (DTIL) (“Precision”), a genome editing company dedicated ...
Precision BioSciences Funding
Precision BioSciences Executive Hires
|2015-09-03||Gene Liau||SVP (Gene Therapy)||Article|
|2017-07-11||David Thomson||Chief Development Officer||Article|
Precision BioSciences New Location/Offices